Cargando…
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
BACKGROUND. Artemisinins are primarily responsible for initial parasite clearance. Antimalarial pharmacokinetics (PK), human immunodeficiency virus (HIV) infection, and antiretroviral therapy have been shown to impact treatment outcomes, although their impact on early parasite clearance in children...
Autores principales: | Kajubi, Richard, Huang, Liusheng, Were, Moses, Kiconco, Sylvia, Li, Fangyong, Marzan, Florence, Gingrich, David, Nyunt, Myaing M., Ssebuliba, Joshua, Mwebaza, Norah, Aweeka, Francesca T., Parikh, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5170492/ https://www.ncbi.nlm.nih.gov/pubmed/28018925 http://dx.doi.org/10.1093/ofid/ofw217 |
Ejemplares similares
-
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria
por: Nyunt, Myaing M., et al.
Publicado: (2016) -
Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
por: Parikh, Sunil, et al.
Publicado: (2016) -
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial
por: Whalen, Meghan E, et al.
Publicado: (2022) -
Strong correlation of lumefantrine concentrations in capillary and venous plasma from malaria patients
por: Huang, Liusheng, et al.
Publicado: (2018) -
Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children
por: Huang, Liusheng, et al.
Publicado: (2017)